0005

Nanjing Red Sun Co.,Ltd. Stock Price

SZSE:000525 Community·CN¥8.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

000525 Share Price Performance

CN¥6.16
0.34 (5.79%)
CN¥6.16
0.34 (5.79%)
Price CN¥6.16

000525 Community Narratives

There are no narratives available yet.

Recent 000525 News & Updates

Here's Why Nanjing Red SunLtd (SZSE:000525) Can Afford Some Debt

Jan 24
Here's Why Nanjing Red SunLtd (SZSE:000525) Can Afford Some Debt

Nanjing Red Sun Co.,Ltd. Key Details

CN¥2.8b

Revenue

CN¥3.1b

Cost of Revenue

-CN¥291.4m

Gross Profit

-CN¥449.8m

Other Expenses

CN¥158.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
Earnings per share (EPS)
0.12
Gross Margin
-10.31%
Net Profit Margin
5.61%
Debt/Equity Ratio
61.4%

Nanjing Red Sun Co.,Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
1 Reward

About 000525

Founded
1991
Employees
2920
CEO
Rongmao Hu
WebsiteView website
www.chinaredsun.com

Nanjing Red Sun Co.,Ltd. engages in the research, manufacture, and sale of pesticides and other chemicals in China. The company offers herbicides, insecticides, fungicides, disinfectants, and three-drug intermediates, as well as fine chemicals. It also provides technical consultation and investment management and consultation services, as well as self-operated and agent Import and export business of commodities and technologies. Nanjing Red Sun Co.,Ltd. was founded in 1991 and is headquartered in Nanjing, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. The market is up 24% over the last 12 months. Looking forward, earnings are forecast to grow by 27% annually. Market details ›